Acute mountain sickness, high altitude cerebral oedema, high altitude pulmonary oedema: The current concepts

Medical Journal Armed Forces India

Volumn 64, Issue 2, 2008, Pages 149-153

  Mehta, S R ^a   Chawla, A ^b   Kashyap, A S ^c  

^a Office of DGAFMS   (India)

^b High Altitude Medical Research Center

^c Command Hospital ^*  (India)

Author keywords

Acute mountain sickness; High altitude cerebral oedema; High altitude pulmonary oedema

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; DEXAMETHASONE; IBUPROFEN; MANNITOL; NIFEDIPINE; NITRIC OXIDE; PARACETAMOL; SALBUTAMOL; SALMETEROL; SILDENAFIL; SULFONAMIDE; TADALAFIL;

ACUTE MOUNTAIN SICKNESS; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CLINICAL ASSESSMENT TOOL; DECOMPRESSION; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; HEADACHE; HIGH ALTITUDE CEREBRAL EDEMA; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HYPOXEMIA; LUNG EDEMA; OXYGEN THERAPY; PATHOPHYSIOLOGY; RISK FACTOR; SYMPTOMATOLOGY;

EID: 44949119553     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(08)80062-7     Document Type: Article

References (37)

1. Gabry AL, Ledoux X, Mozziconacci M, Martin C. High-Altitude pulmonary edema at moderate altitude (2,400 m;7870 feet) A series of 52 patients. Chest 2003; 123:49-53.
2. Roach RC, Bärtsch P, Oelz O, Hackett PH. The Lake Louise acute mountain sickness scoring system. In: Hypoxia and molecular medicine Sutton JR, Houston CS, Coates G, editors. Queen City Printers, Burlington, VT: 1993:272-4.
3. Bartch P, Vock P, Maggiorini M et al. Respiratory symptoms, radiographic and physiologic correlations at high altitude. In: Sutton JR, Cotes G, Remmers JE, eds. Hypoxia: The adaptations. Philadelphia: BC Decker, Inc., 1990:241-5.
4. Bartch P, Baumgartner RW, Waber U, Maggiorini M, Olez O. Comparison of carbon dioxide-enriched, oxygen enriched and normal air treatment of acute mountain sickness. Lancet 1990; 336:772-5.
5. Hohenhaus E, Paul A, Bartch P. Hypoxic ventilatory response and gas exchange in acute mountain sickness. Eur Respir J 1994; 7: 200.
6. Krasney JA. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc 1994; 26:195-208.
7. Hackett PH. High altitude cerebral edema and acute mountain sickness: a pathophysiology update. In: Roach RC, Wagner PD, Hackett PH. editors. Hypoxia: into the next millennium. Vol. 474 of Advances in experimental medicine and biology. New York: Kluwer Academic/Plenum, 1999:23-45.
8. Kilgore D, Loeppky J, Sanders J, Caprihan A, Icenogle M, Roach RC. Corpus callosum (CC) MRI: early altitude exposure. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia: into the next millennium. Vol. 474 of Advances in experimental medicine and biology. New York: Kluwer Academic/ Plenum, 1999:396-7.
9. Muza SR, Lyons TP, Rock PB, et al. Effects of altitude exposure on brain volume and development of AMS (abstr). In: Roach RC, Hackett PH, Wagner PD, editors. Hypoxia: Into the next millennium. New York: Plenum/Kluwer Academic Publishing 1999; 414.
10. Icenogle M, Kilgore D, Sanders J, Caprihan A, Roach RC. Cranial CSF volume is reduced by attitude exposure but is not related to early AMS (abstr). In: Roach RC, Hackett PH, Wagner PD, editors. Hypoxia: Into the next millennium. New York: Plenum/Kluwer Academic Publishing 1999; 392.
11. Moskowitz MA. Basic mechanisms in vascular, headache. Neurology 1990; 8:801-15.
12. Bartch P, Roach R. Acute mountain sickness and high altitude cerebral edema. In: Hornbein TF, Schoene RB, eds. High altitude: An exploration of human adaptation. New York: Marcel Dekker Inc., 2001; 752.
13. Grover RF, Tucker A, Reeves JT. Hypobaria: an etiologic factor in acute mountain sickness. In: Loeppky JA, Riedesel ML, eds. Oxygen transport to human tissue. New York: Elsevier/North Holland, 1982:223-30.
14. Roach RC, Loeppky JA, Robergs R. Fluid balance in humans at HA: Does hypobaria play a role. FASEB J 1994; 8:A553.
15. Bartch P, Bailey DM, Berger M M, Knauth M, Baumgartner R. Acute mountain sickness: controversies and advances. High Alt Med Biol 2004; 5:110-24.
16. Hildebrandt W, Buclin T, Swenson E, Bartch P, Biollaz J. Development of acute mountain sickness without sodium and fluid retention (abstr). Int J Sports Med 1998; 19:S16.
17. Hackett PH, Roach RC. High altitude illness. N Engl J Med 2001; 345:107-14.
18. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 1998; 280:1920-5.
19. Jensen JB, Sperling B, Severinghaus JW, Lassen NA. Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude. J Appl Physiol 1996; 80:1214-8.
20. Levine BD, Zhang R, Roach RC. Dynamic cerebral autoregulation at high altitude. In: Roach RC, Wagner PD, Hackett PH, eds. Hypoxia: into the next millennium. Vol. 474 of Advances in experimental medicine and biology. New York: Kluwer Academic/Plenum, 1999:319-22.
21. Severinghaus JW. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J Appl Physiol 1995; 79:375-9.
22. Schilling L, Wahl M. Mediators of cerebral edema. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia: into the next millennium. Vol. 474 of Advances in experimental medicine and biology. New York: Kluwer Academic/ Plenum, 1999:123-41.
23. Hultgren HN. High-altitude pulmonary edema: current concepts. Annu Rev Med 1996; 47:267-84.
24. Maggiorini M, Melot C, Pierre S, et al. High altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103:2078-83.
25. Elser H, Swenson E, Hildebrandt J, et al. Regional distribution of pulmonary perfusion after five hours of normobaric hypoxia in subjects susceptible to high altitude pulmonary edema. Eur Respir J 1998; 12:A2328.
26. Schoene RB, Swenson ER, Hultgren HN. High altitude pulmonary edema. In: Hornbein TF, Schoene RB, eds. High altitude: An exploration of human adaptation. New York: Marcel Dekker Inc., 2001; 793-4.
27. Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bartsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary edema. Eur Respir J 1995; 8:1825-33.
28. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, et al. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 1999; 99:1713-8.
29. Kubo K, Hanaoka M, Hayano T, et al. Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema. Respir Physiol 1998; 111:301-10.
30. Scherrer U, Sartori C, Lepori M, et al. High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia: into the next millennium. Vol. 474 of Advances in experimental medicine and biology. New York: Kluwer Academic/Plenum, 1999:93-107.
31. Hanaoka M, Kubo K, Yamazaki Y, et al. Association of high altitude pulmonary edema with major histocompatibility complex. Circulation 1998; 97:1124-8.
32. Maggiorini M, Brunner-La Roccca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high altitude pulmonary edema. A randomized trial. Ann Int Med 2006; 145:497-506.
33. Sartori C, Lipp E, Duplain H, et al. Prevention of HAPE by beta-adrenergic stimulation of the alveolar transepithelial sodium transport. Am J Crit Care Med 2000; 161: Suppl: A415.
34. Hackett PH, Roach RC, Hartig GS, Greene ER, Levine BD. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int J Sports Med 1992; 13: Suppl 1:S68-S71.
35. West JB. The Physiological Basis of High-Altitude Diseases. Ann Intern Med 2004; 141:789-800.
36. Barry JW, Pollard AJ. Altitude illness. BMJ 2003; 326:915-9.
37. Dumont L, Mardirosoff C, Tramer MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systemic review. BMJ 2000; 321:267-72.